We are live on ! Find out more
HT

HAP Trading Portfolio holdings

AUM $1.42B
1-Year Est. Return 41.92%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+41.92%
3 Year Est. Return
+140.6%
5 Year Est. Return
+193.92%
10 Year Est. Return
+737.23%
AUM
$3.66B
AUM Growth
+$580M
Cap. Flow
+$878M
Cap. Flow %
24.02%
Top 10 Hldgs %
32.83%
Holding
3,064
New
672
Increased
1,002
Reduced
783
Closed
579

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$65.6M
2
W icon
Wayfair
W
+$37.1M
3
ARMK icon
Aramark
ARMK
+$28.6M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$28.1M
5
GTLB icon
GitLab
GTLB
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 6.12%
2 Healthcare 3.66%
3 Communication Services 3.55%
4 Financials 3.43%
5 Consumer Discretionary 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRNA
3026
PUT
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-11,300
Closed -$62K
REML
3027
DELISTED
Credit Suisse X-Links Monthly Pay 2xLeveraged Mortgage REIT ETN
REML
-151,391
Closed -$1.05M
LMRK
3028
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
-65,714
Closed -$1.07M
KSU
3029
CALL
DELISTED
Kansas City Southern
KSU
-15,200
Closed -$82K
KSU
3030
PUT
DELISTED
Kansas City Southern
KSU
-11,700
Closed -$196K
DCRC
3031
PUT
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
-14,500
Closed -$4K
AGC
3032
CALL
DELISTED
Altimeter Growth Corp
AGC
-40,100
Closed -$3K
CVA
3033
DELISTED
Covanta Holding Corporation
CVA
-37,143
Closed -$747K
XLRN
3034
CALL
DELISTED
Acceleron Pharma
XLRN
-21,000
Closed -$56K
TRIL
3035
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
-63,100
Closed -$18K
TRIL
3036
DELISTED
Trillium Therapeutics Inc.
TRIL
-72,458
Closed -$1.27M
TRIL
3037
PUT
DELISTED
Trillium Therapeutics Inc.
TRIL
-10,600
Closed -$2K
XONE
3038
DELISTED
The ExOne Company
XONE
-105,303
Closed -$2.46M
KDMN
3039
DELISTED
Kadmon Holdings, Inc.
KDMN
-140,951
Closed -$1.23M
KDMN
3040
PUT
DELISTED
Kadmon Holdings, Inc.
KDMN
-13,600
Closed -$5K
RTPYU
3041
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
-30,000
Closed -$303K
MDLA
3042
DELISTED
Medallia, Inc.
MDLA
-45,162
Closed -$1.53M
RPAI
3043
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
-93,202
Closed -$1.2M
SCR
3044
PUT
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
-10,400
Closed -$1K
CLDR
3045
CALL
DELISTED
Cloudera, Inc.
CLDR
-36,500
Closed -$35K
CLDR
3046
DELISTED
Cloudera, Inc.
CLDR
-35,705
Closed -$570K
CLDR
3047
PUT
DELISTED
Cloudera, Inc.
CLDR
-21,300
Closed -$1K
IEC
3048
CALL
DELISTED
IEC Electronics Corp.
IEC
-12,600
Closed -$3K
AVEO
3049
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-21,950
Closed -$4K
GNCA
3050
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
-12,700
Closed -$3K

Similar funds

HAP Trading's Q4 2021 Portfolio in Review

As of Q4 2021, HAP Trading held 3,064 positions worth $3.66B, up 19% from $3.08B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

HAP Trading deployed $878M of net new capital in Q4 2021, opening 672 new positions and adding to 1,002 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 543,830 shares worth $60.9M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 6.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Scotiabank, an estimated $14.8M trimmed.

  • HAP Trading's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 543,830 shares worth $60.9M.
  • HAP Trading added most to Aramark in Q4 2021, an estimated $28.6M increase.
  • HAP Trading's biggest Q4 2021 reduction was Scotiabank, cutting an estimated $14.8M.
  • HAP Trading fully exited State Street SPDR S&P 500 ETF Trust in Q4 2021, selling an estimated $102M.
  • HAP Trading's ten largest holdings make up 33% of its $3.66B portfolio in Q4 2021.
  • HAP Trading opened 672 new positions and closed 579 in Q4 2021.
  • HAP Trading's portfolio value rose 19% quarter-over-quarter to $3.66B.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.